Clinical characteristics and outcome of 32 patients with long-QT syndrome accompanied with torsade de pointes.
	    		
		   		
		   			
		   		
	    	
    	- VernacularTitle:QT间期延长伴尖端扭转型室性心动过速32例的治疗及随访
 - Author:
	        		
		        		
		        		
			        		Cui-hong HOU
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Jing-tao ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Xiao-xing ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Ke-ping CHEN
			        		
			        		;
		        		
		        		
		        		
			        		Wei HUA
			        		
			        		;
		        		
		        		
		        		
			        		Shu ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Jie-lin PU
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Journal Article
 - MeSH: Adolescent; Adult; Aged; Female; Follow-Up Studies; Humans; Long QT Syndrome; complications; therapy; Male; Middle Aged; Pacemaker, Artificial; Torsades de Pointes; complications; therapy; Treatment Outcome; Young Adult
 - From: Chinese Journal of Cardiology 2011;39(4):297-300
 - CountryChina
 - Language:Chinese
 - 
		        	Abstract:
			       	
			       		
				        
				        	
OBJECTIVETo summarize the clinical characteristics and outcome of patients with long-QT syndrome (LQTs) accompanied with torsade de pointes.
METHODSThirty-two eligible patients were included in this study. Clinical and electrocardiographic data were analyzed and telephone or out-patient follow-up were made in all patients.
RESULTSThere were 15 patients with inherited LQTs (h-LQTs) and 17 patients with acquired LQTs (a-LQTs). There are more women (n = 24) than men (n = 8). β blockers, potassium and magnesium supplement were the basic therapy for h-LQTs patients, bivent pacemaker was implanted in 2 patients and implantable cardioverter defibrillator was implanted in 5 patients. Ventricular tachyarrhythmias and syncope occurred in 4 patients during (39.4 ± 25.1) months follow-up. In 17 a-LQTs patients, one patient with dilated cardiomyopathy died suddenly and another patient with implanted cardioverter defibrillator experienced one ventricular tachycardia during (30.9 ± 13.3) months follow-up.
CONCLUSIONSThe prognosis in h-LQTs and a-LQTs patients with structure heart disease is poor. ICD or CRT-D therapy is suggestive for a-LQTs patients with structure heart disease.
 
            